• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Corcept Therapeutics Incorporated (CORT)

    -NasdaqCM
    3.20 0.00(0.00%) 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 7,282   5,850   4,405   4,115  
    Cost of Revenue235  215  174  61  
    Gross Profit 7,047   5,635   4,231   4,054  
    Operating Expenses
    Research Development3,046  4,252  7,285  6,567  
    Selling General and Administrative9,103  7,964  9,805  7,517  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (5,102) (6,581) (12,859) (10,030)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes(5,102)(6,581)(12,859)(10,030)
    Interest Expense905  970  1,071  1,094  
    Income Before Tax(6,007)(7,551)(13,930)(11,124)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(6,007)(7,551)(13,930)(11,124)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (6,007) (7,551) (13,930) (11,124)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (6,007) (7,551) (13,930) (11,124)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.